TB medicine deal offers short-term solution, but J&J needs to do more for all affected countries
July 14, 2023Christophe Perrin, TB advocacy pharmacist, MSF Access Campaign "Today's announcement by the Stop TB Partnership/Global Drug Facility about a deal with pharmaceutical corporation Johnson & Johnson (J&J), for access to affordable generic versions of the lifesaving tuberculosis (TB) drug bedaquiline, offers...
Read more
MSF calls on Gavi to step up efforts to improve vaccine access for children up to at least five years old
June 12, 2023Geneva, 12 June 2023 – Médecins Sans Frontières/Doctors Without Borders (MSF) today again urged Gavi, the Vaccine Alliance, to urgently prioritise reaching ‘zero-dose’* and under-immunised children up to age five, by removing barriers to broadening vaccine coverage for unprotected children,...
Read more
MSF demands J&J give up its patent monopoly on TB drug to put lives over profits
April 27, 2023Access to TB drug bedaquiline, a backbone medicine for drug-resistant TB treatment regimens, remains out of reach for too many Geneva, 26 April 2023 – Ahead of Johnson & Johnson’s (J&J) annual shareholders meeting, the international medical humanitarian organisation Médecins...
Read more
Pharmaceutical corporation ViiV must improve its failing access strategy for lifesaving HIV prevention drug
March 31, 2023With affordable generics likely years away, ViiV must make information public on supply of long-acting cabotegravir and global distribution plan to ensure access for people in high HIV burden low- and middle-income countries Geneva, 30 March 2023 – Today Médecins...
Read more
Pharmaceutical corporation ViiV must make ground-breaking HIV prevention injection affordable and available
November 30, 2022MSF calls on ViiV to urgently dismantle barriers to access for long-acting cabotegravir Geneva, 29 November 2022 - Doctors Without Borders/Médecins Sans Frontières (MSF) today called on pharmaceutical corporation ViiV to urgently dismantle the barriers hindering broad access to the...
Read more
MSF is disappointed with the inadequate outcome after nearly two years of discussions at the WTO
June 17, 2022Today, more than 20 months since India and South Africa first proposed a landmark intellectual property (IP) Waiver for COVID-19 medical tools at the World Trade Organization (WTO), governments have reached a decision at the 12th WTO Ministerial Conference in...
Read more
Breakthrough in treatment of HIV-related cryptococcal meningitis gives Gilead another opportunity to fulfil its promise to scale up access to lifesaving drug
July 21, 2021Today, as preliminary AMBITION trial results demonstrated a breakthrough in treatment of HIV-related cryptococcal meningitis, simplifying and shortening treatment by using a single dose of liposomal amphotericin B (L-AmB) in combination with existing oral therapy, Médecins Sans Frontières/Doctors Without Borders...
Read more
EU, UK, Switzerland, Norway must stop blocking negotiations on landmark pandemic monopoly waiver
June 7, 2021Ahead of the next World Trade Organization (WTO) meeting on the landmark pandemic monopoly waiver proposal — the ‘TRIPS waiver’ — the international humanitarian organisation Médecins Sans Frontières/Doctors Without Borders (MSF) denounced the European Union (EU) and countries including the...
Read more
COVID-19: Governments must act fast on consensus supporting historic move to suspend monopolies during pandemic
December 15, 2020Over 100 countries support the landmark proposal Geneva —Ahead of a critical meeting at the World Trade Organization (WTO) tomorrow — and against the backdrop of COVID-19 cases surging globally — the international medical humanitarian organisation Médecins Sans Frontières /Doctors...
Read more
Access to Medicines: In landmark move, India and South Africa propose no patents on COVID-19 medicines, tools during pandemic
October 7, 2020Governments make request to WTO for intellectual property waiver for all countries until herd immunity reached Geneva - In a landmark move, India and South Africa on 2 October asked the World Trade Organization (WTO) to allow all countries to...
Read more
COVID-19 vaccine: 6 recommendations for equitable access
June 22, 2020We're in a time of unprecedented mobilisation to tackle COVID-19. We're in a time of unprecedented mobilisation to tackle COVID-19. Governments and philanthropies have contributed billions to the research and development of COVID-19 vaccines, while Gavi, the Vaccine Alliance, has recently launched...
Read more
Access to medicines: MSF demands review of USTR Special 301 report on trade barriers
February 7, 2020In a letter to the United States Trade Representative (USTR) on 6th February 2020, Médecins Sans Frontières (MSF)/Doctors Without Borders submitted comments to the review process of USTR’s 2020 Special 301 Report and raised concerns of the public health impact of...
Read more
